Recent population data have demonstrated a 50% reduction in legal blindness caused by age-related macular degeneration in certain nations following the advent of drugs that decrease vascular endothelial growth factor (VEGF), known as VEGF antagonists. This evidence concerns the gene VEGFA and blindness (disorder).